md-medicaldata

Authors

Sara Šekerović¹, Dejan Ogorelica <sup>1,2

1</sup>Univerzitet u Novom Sadu, Medicinski fakultet Novi Sad, Srbija
²Univerzitetski klinički centar Vojvodine, Klinika za kožno-venerične bolesti

 

UDK: 618.39-021.3

The paper was received / Rad primljen 10.05.2025.

Accepted / Rad prihvaćen: 21.05.2025.

 

Correspondence to:

Sara Šekerović,
Univerzitet u Novom Sadu,
Medicinski fakultet Novi Sad, Srbija
Hajduk Veljkova 3,
21000, Novi Sad
e-mail: sara.sekerovic@gmail.com

 

 

Sažetak

 

 

Uvod: Najčešći nemelanomski karcinomi kože su bazocelularni karcinom i skvamocelularni karcinom kože i na godišnjem nivou se dijagnostikuju kod oko 2 miliona osoba širom sveta. U nastanku nemelanomskih karcinoma kože značajnu ulogu ima hronična ekspozicija sunčevom zračenju, koje svojim kumulativnim negativnim efektom dovodi do nastanka atipije u ćelijama epidermisa. Cilj rada: Utvrditi demografske karakteristike ispitanika i najčešće dijagnostikovan nemelanomski karcinom kože. Utvrditi povezanost patohistološke dijagnoze ekscidiranih lezija i anatomske lokalizacije, kao i analizu distribucije patohistološke dijagnoze ekscidiranih lezija spram pola i starosnih grupa. Materijal i metode: Istraživanje je sprovodeno kao retrospektivna studija koja uključuje analizu i obradu podataka iz medicinske dokumentacije 108 pacijenata dijagnostikovanih i lečenih na Klinici za kožno-venerične bolesti Univerzitetskog kliničkog centra Vojvodine u periodu od 1. oktobra 2022. godine do 1. oktobra 2023. godine. Rezultati: Kao rezultat histopatološke analize lezija, koje su eksicidirane radi potvrde i isključenja alteracije, utvrđeno je prisustvo 6 različitih histoloških tipova tumora. Najveća prevalenca je uočena kod bazocelularnog karcinoma sa 87 slučajeva, dok je na drugom mestu skvamocelularni karcinom sa 8 slučajeva. Zaključak: Distribucija ispitanika prema polu je gotovo izjednačena, a najveći broj pacijenata je u starosnoj grupi od 70 do 79 godina. U istraživanju se kao najčešće histopatološki verifikovan nemelanomski karcinom kože izdvaja bazocelularni karcinom, a uočena je i statistički značajna povezanost između pojave bazocelularnog karcinoma i lokalizacije na trupu.

 

Ključne reči:

nemelanomski karcinom kože; bazocelularni karcinom kože; skvamocelularni karcinom kože; dermoskopija

 

 

 

Abstract

 

Introduction: The most common non-melanoma skin cancers are basal cell carcinoma and squamous cell carcinoma, which are diagnosed in approximately 2 million people worldwide each year. Non-melanoma skin cancer is predominantly a result of chronic exposure to ultraviolet radiation, which, through its cumulative negative effects, leads to the development of atypia in the epidermal cells. The aim: To determine the demographic characteristics of the participants and the most commonly diagnosed non-melanoma skin cancers. Identify the association between the histopathological diagnosis of excised lesions and anatomical location, as well as to analyze the distribution of histopathological diagnoses of excised lesions with respect to gender and age groups. Material and methods: The research was a retrospective study analyzing data from the medical records of 108 patients diagnosed and treated at the Clinic for Dermatology and Venereology of the University Clinical Center of Vojvodina between October 1, 2022, and October 1, 2023. Results: As a result of the histopathological analysis of the lesions, which were excised for the purpose of confirmation and exclusion of alterations, the presence of six distinct histological tumor types was identified. The highest prevalence was observed for basal cell carcinoma, with 87 cases, followed by squamous cell carcinoma with 8 cases. Conclusion: The distribution of participants by gender was nearly balanced, with the majority of patients in the 70 to 79 age group. Basal cell carcinoma emerged as the most commonly histopathologically confirmed non-melanoma skin cancer, and a statistically significant association was found between the occurrence of basal cell carcinoma and its localization on the trunk.

 

Key words:

non-melanoma skin cancer; basal cell carcinoma; squamous cell carcinoma; dermoscopy

 

 

 

 

References:

1. Attal ZG, Shalata W, Soklakova A, Tourkey L, Shalata S, Abu Saleh O et al. Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options. Biomedicines. 2024;12(7):1448.
2. Deinlein T, Richtig G, Schwab C, Scarfi F, Arzberger E, Wolf I, et al. The use of dermatoscopy in diagnosis and therapy of nonmelanocytic skin cancer. J Dtsch Dermatol Ges. 2016;14(2):144-51.
3. Samarasinghe V, Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg. 2012;5(1):3-10.
4. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200-6.
5. Ishioka P, Marques SA, Hirai AT, Marques ME, Hirata SH, Yamada S. Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, São Paulo State, Brazil. Cad Saude Publica. 2009;25(5):965-71.
6. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327(7418):794-8.
7. Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013;4(1):12-7.
8. Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, Williford PM, Feldman SR. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035-8.
9. Puig S, Berrocal A. Management of high-risk and advanced basal cell carcinoma. Clin Transl Oncol. 2015;17(7):497-503.
10. Reggiani C, Manfredini M, Mandel VD, Farnetani F, Ciardo S, Bassoli S, et al. Update on non-invasive imaging techniques in early diagnosis of non-melanoma skin cancer. G Ital Dermatol Venereol. 2015;150(4):393-405.
11. Burton KA, Ashack KA, Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am J Clin Dermatol. 2016;17(5):491-508.
12. Zhou C, Jiang B, Zhang K, Wu J, Huang C, Xu N et al. Clinical and histopathological characteristics, diagnosis and treatment, and comorbidities of Bowen's disease: a retrospective study. Front Med (Lausanne). 2023;10:1281540.
13. Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J. Interventions for cutaneous Bowen's disease. Cochrane Database Syst Rev. 2013;2013(6):CD007281.
14. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673-85.
15. Fargnoli MC, Kostaki D, Piccioni A, Micantonio T, Peris K. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol. 2012;22(4):456-63.
16. Rezze GG, Scramim AP, Neves RI, Landman G. Structural correlations between dermoscopic features of cutaneous melanomas and histopathology using transverse sections. Am J Dermatopathol. 2006;28(1):13-20.
17. Lallas A, Zalaudek I, Argenziano G, Longo C, Moscarella E, Di Lernia V, Al Jalbout S, Apalla Z. Dermoscopy in general dermatology. Dermatol Clin. 2013;31(4):679-94.
18. 18 Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673-85.
19. Simić M, Gajić B, Ogorelica D, Gajinov Z. Diagnostic accuracy of basal cell carcinoma in dermatology setting in Serbia–a single-center study. Vojnosanit pregl. 2022;79(6).
20. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069-80.
21. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol. 2004;140(7):837-42.
22. Lalević-Vasić B, Medenica Lj, Nikolić M. Dermatovenerologija sa propedevtikom. 10. izd. Beograd: Medicinski fakultet Univerziteta CIBID; 2022.
23. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):43-50.
24. Didona D, Paolino G, Bottoni U, Cantisani C. Non Melanoma Skin Cancer Pathogenesis Overview. Biomedicines. 2018;6(1):6.
25. Calzavara-Pinton P, Ortel B, Venturini M. Non-melanoma skin cancer, sun exposure and sun protection. G Ital Dermatol Venereol. 2015;150(4):369-78.
26. Sari E. Non-metastatic Non-melanoma Skin Cancers: Our 3 Years of Clinical Experiences. World J Plast Surg. 2017;6(3):305-312.
27. Muntyanu A, Ghazawi FM, Nedjar H, Rahme E, Alakel A, Zubarev A et al. Non-Melanoma Skin Cancer Distribution in the Russian Federation. Dermatology. 2021;237(6):1007-1015.
28. Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjær SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women. Int J Cancer. 2010;127(9):2190-8.
29. Musah A, Gibson JE, Leonardi-Bee J, Cave MR, Ander EL, Bath-Hextall F. Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10). Br J Dermatol. 2013;169(5):1093-9.
30. Calzavara-Pinton P, Ortel B, Venturini M. Non-melanoma skin cancer, sun exposure and sun protection. G Ital Dermatol Venereol. 2015;150(4):369-78.
31. Koyuncuer A. Histopathological evaluation of non-melanoma skin cancer. World J Surg Oncol. 2014;12:159.
32. Khalid A, van Essen P, Crittenden TA, Dean NR. The anatomical distribution of non-melanoma skin cancer: a retrospective cohort study of 22 303 Australian cases. ANZ J Surg. 2021;91(12):2750-2756.
33. Chopra K, Calva D, Sosin M, Tadisina KK, Banda A, De La Cruz C, et al. A comprehensive examination of topographic thickness of skin in the human face. Aesthet Surg J. 2015;35(8):1007-13.
34. Tisack A, Fotouhi A, Fidai C, Friedman BJ, Ozog D, Veenstra J. A clinical and biological review of keratoacanthoma. Br J Dermatol. 2021;185(3):487-498.
35. Ogita A, Ansai SI. What Is a Solitary Keratoacanthoma? A Benign Follicular Neoplasm, Frequently Associated with Squamous Cell Carcinoma. Diagnostics (Basel). 2021;11(10):1848.
36. Shih S, Khachemoune A. Acquired digital fibrokeratoma: review of its clinical and dermoscopic features and differential diagnosis. Int J Dermatol. 2019;58(2):151-158.
    

PDF: 01-Šekerović and Ogorelica MD-Medical Data 2025;17(2) 087-093.pdf